site stats

Biolytx pharmaceuticals corp

WebBiolytx Pharmaceuticals Corp. Jan 2016 - May 2024 3 years 5 months. Oklahoma City, Oklahoma Vice President and General Counsel Amicus Therapeutics ... WebNov 11, 2015 · Biolytx Pharmaceuticals picks up $1.1 mill By Iris Dorbian ... Biolytx is developing a promising drug designed to promote wound healing and kill antibiotic resistant bacteria. This latest financing round also included $200,000 from the i2E-managed SeedStep Angels group, as well as $250,000 from an Oklahoma venture capital fund and …

AstraZeneca - i2E

WebNov 9, 2015 · Biolytx Pharmaceuticals Corp., which is developing a drug designed to promote wound healing and kill antibiotic resistant bacteria, has raised a $1.1 million financing round led by i2E Inc ... WebBiolytx Pharmaceuticals is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center. Still in the pre-clinical trial stage, the company's core technology is the development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those ... registar poslovnih subjekata republika srpska https://harringtonconsultinggroup.com

Biolytx Pharmaceuticals - Products, Competitors, Financials, …

WebBIOLYTX PHARMACEUTICALS CORP VentureRadar profile. Find out more about BIOLYTX PHARMACEUTICALS CORP including the VentureRadar Innovation and … WebBiolytx Pharmaceuticals. Drug Stores & Pharmacies · Oklahoma, United States · <25 Employees . Founded in 2005 by H. Anne Pereira, Ph.D., and William A. Hagstrom, Biolytx is a pharmaceutical technology company developing a novel antibiotic peptide for potential use in wound healing and treatment of serious hospital-acquired infections, including … WebBiolytx Pharmaceuticals Corp. Research Services Oklahoma City, Oklahoma Amethyst Research, Inc. Defense and Space Manufacturing Ardmore, Oklahoma Humanity Hospice, LLC ... registar ponudjaca za javne nabavke

Biolytx Pharmaceuticals picks up $1.1 mill - Oklahoma …

Category:corpInformation

Tags:Biolytx pharmaceuticals corp

Biolytx pharmaceuticals corp

Oklahoma’s life science startup companies take a different route

WebFounded Date 2005. Founders H. Anne Pereira, William Hagstrom. Operating Status Active. Last Funding Type Seed. Company Type For Profit. Contact Email … WebOklahoma City, OK. 264 Total Employees. Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in clinical and commercial manufacturing production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company ...

Biolytx pharmaceuticals corp

Did you know?

WebJan 26, 2024 · BioFilm Pharma Biolytx Pharmaceuticals Biosergen BioVersys GmbH C3J Therapeutics, Inc Centauri Therapeutics Ltd Cipla Combioxin SA Contrafect Corporation Da Volterra Debiopharm International SA ... WebOKLAHOMA CITY, OK — A $500,000 investment from the i2E, Inc.-managed Oklahoma Seed Capital Fund recently led a $1.1 million financing round in Oklahoma City-based …

WebBiolytx Pharmaceuticals Corp . Profile last edited on: 3/24/2024 CAGE: 7D9G6 UEI: LBXKMFJ5KQA3. Drug for promoting wound healing and killing antibiotic resistant … WebJul 8, 2015 · Biolytx Pharmaceuticals has a novel new drug developed from a peptide (a small part of a protein) that is created by the human body. ... a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology.

WebCherryvale, KS 67335. $16.50 - $17.00 an hour. Full-time. Monday to Friday + 5. Easily apply. Urgently hiring. Training- Days - Monday through Thursday- 6am- 4pm for 2 … WebBiolytx Pharmaceuticals is an example of what life science companies go through. Biolytx has developed a novel new drug to fight antibiotic-resistant bacteria. ... Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from ...

WebIn 2005, she founded a company called Biolytx Pharmaceuticals Corp. to take her peptide discoveries to the marketplace. For almost a decade, Pereira and her Biolytx team have worked to prepare a therapeutic based on the CAP37 peptide that will kill drug-resistant bacteria. Biolytx is specifically targeting serious hospital-acquired infections.

WebBiolytx Pharmaceuticals. Drug Stores & Pharmacies · Oklahoma, United States · <25 Employees . Founded in 2005 by H. Anne Pereira, Ph.D., and William A. Hagstrom, … registar poslovnih subjekata sarajevoWebFeb 24, 2011 · Anne Pereira is scientific founder of Biolytx Pharmaceuticals Corp., a six-year-old Oklahoma City biotech company whose research stands to have a global reach. Her work began 25 years ago while she was a postdoctoral student at Emory University, and it continues today as a professor and associate dean for research and paid surveys in the ... dz palilula stomatologijaWebBiolytx Pharmaceuticals Corp: Street Address 1 Street Address 2; 800 RESEARCH PARKWAY: SUITE 334: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; OKLAHOMA CITY: OKLAHOMA: 73104: 405-271-6593: 3. Related Persons. Last Name First Name Middle Name; Hagstrom: William: A: Street Address 1 Street Address … dzovak kazandjianWebBiolytx has a portfolio of antimicrobial peptides based on the naturally occurring human CAP37 (Cationic Antimicrobial Peptide), which is one of the proteins secreted at wound … dz oven\u0027sWebBiolytx Pharmaceuticals is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center. Still in the pre-clinical … dz oval\u0027sWebOct 16, 2015 · Biolytx Pharmaceuticals General Information Description Developer of peptide-based antibiotics designed to treat serious pathogens with no current therapeutic … dz period\u0027sdžozef konrad srce tame